A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.
about
How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?Contrast Medium-Induced Acute Kidney InjuryPrevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.Prophylaxis of contrast-induced nephrotoxicityRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesPreventing contrast-induced nephropathy: problems, challenges and future directions.Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study.Contrast-induced acute kidney injury: short- and long-term implications.Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice.Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysisEvaluation of the protective effect of N-acetylcysteine on contrast media nephropathyContrast-induced nephropathy following angiography and cardiac interventionsN-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients.Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathyN-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.TACE versus TAE as therapy for hepatocellular carcinoma.Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy.Pharmacological strategies to prevent contrast-induced acute kidney injury.Obesity is not associated with contrast nephropathyNephrotoxicity of contrast media and protective effects of acetylcysteine.Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiN-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.Imaging of acute pulmonary embolism.Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery.Renal-related adverse effects of intravenous contrast media in computed tomography.Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.Update on the renal toxicity of iodinated contrast drugs used in clinical medicine.Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists.Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.Bicarbonates for the prevention of postoperative renal failure in endovascular aortic aneurysm repair: a randomized pilot trial.Contrast-induced acute kidney injury: the importance of diagnostic criteria for establishing prevalence and prognosis in the intensive care unitComparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy.
P2860
Q26765146-3F69E4ED-3B2D-424E-8AF5-56553760253CQ26801447-BF813371-8A9C-46EF-A8CD-3E236271A9C9Q26823226-35662305-98A5-4EBA-9887-4F87D7A9A35AQ27012899-F5D6647D-18FE-41A5-8C40-75CE78624DDEQ27021421-81ACA00E-5EA5-4BEE-9DA6-E77D27E3C76BQ33445312-4E3376B5-FE61-421A-A021-73FC0383504BQ33843623-A1EC368D-1447-4678-AE89-2FB766F8E388Q34150613-D17B24E3-7F08-439B-9919-63DF6D63E71DQ34753666-98971266-1126-41A7-A894-ACE46418C4E9Q35127308-5DE27351-B536-4E5B-801F-4E2B751FB0C5Q35882934-7820576A-42E3-4767-84B5-254ABA61FF26Q35930002-6504316C-1309-42CA-9611-C89249C1787DQ35999430-A9349869-D578-4168-B88E-A9916354761DQ36060153-195E6BD0-F926-49CA-877F-0FFBB72EB8D9Q36389997-D149B9FC-333E-497F-BCC4-D432442D5F82Q36761998-486C775B-0C20-4949-A042-32EDAA0FD4DAQ36947309-08528932-35F0-4EEA-9959-9348795D7F20Q37251655-15ED3AD6-A5B3-407B-9A57-5FB7851F0E17Q37271293-576906E4-FA6B-42F6-9A22-6C201838AE79Q37300023-99BC6A67-3D68-4DEF-8978-C61A3116CACEQ37353089-EBDB9967-EDFA-4C9A-9884-BF4D97D72597Q37477897-C314BD31-EF05-4F53-8F00-E81A103999AAQ37639849-6784C406-AEA5-4B37-8E98-263220D917ECQ37762982-513C8F5D-8F6B-421E-9623-3BAF976DB42AQ37817813-C8A89268-7065-44B9-A7F9-6E62BE9D30F4Q37826019-05B61C1B-94C4-4998-AE4C-2DEC14C2EE3BQ37922124-E7BDE090-5CB4-4343-B9CC-ACCAAABDF88EQ37953885-C3095666-C719-465E-8C5F-2B4D0D760F3CQ37977061-8770D4B4-E821-46C7-814F-6EF727F94E8BQ38059815-A85392A0-7D29-4DB7-B5DA-691BCD24A189Q38067457-3C6ABCA5-9C41-4EE1-9319-3CFA4A05FB95Q38192579-F9E89223-DBCD-491F-8101-55511B4F13BAQ38445166-7AFD7BB8-6C1D-4A2E-B8CE-39A8934434DEQ39192213-DB49519C-2171-45EE-A63B-A3026110EF4FQ39349844-9B874A9C-475E-4D8C-8C99-CA28EC3871EEQ39674875-0E7F5EEE-4F94-4C2C-9D07-563ED8882CEFQ41140599-43530A20-3A4D-4FB1-8C6C-CE43AD0CE676Q41570370-E82BC3F6-8598-41F6-8F43-E3CD719CD042Q42269781-7DDB7A10-1109-4FDC-B1FE-40376266876BQ42567312-0B7D7DA8-9FB2-4AC9-869A-62A595DE8578
P2860
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@ast
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@en
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@nl
type
label
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@ast
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@en
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@nl
prefLabel
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@ast
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@en
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@nl
P2093
P2860
P356
P1433
P1476
A meta-analysis of N-acetylcys ...... ring to resolve heterogeneity.
@en
P2093
Charles Natanson
Denise A Gonzales
Kelly J Norsworthy
Robert A Star
Robert L Danner
Steve Banks
Steven J Kern
P2860
P2888
P356
10.1186/1741-7015-5-32
P407
P577
2007-11-14T00:00:00Z
P5875
P6179
1000544378